title: Activation of matrix metalloproteinase-9 is associated with mobilization of bone marrow-derived cells after coronary stent implantation.
abstract: BACKGROUND
  After stent-related vascular injury, an inflammatory response triggers the mobilization of bone marrow-derived stem cells, including both endothelial and smooth muscle progenitors, leading to re-endothelialization as well as restenosis. It has been postulated that neutrophil-released matrix metalloproteinase-9 (MMP-9) induces stem cell mobilization.
  
  
  OBJECTIVE
  To elucidate the mechanistic link between inflammation and stem cell mobilization after coronary stenting.
  
  
  METHODS
  In 31 patients undergoing coronary stenting, we serially measured activated Mac-1 on the surface of neutrophils and active MMP-9 levels in the coronary sinus blood plasma, and the number of circulating CD34-positive cells in the peripheral blood.
  
  
  RESULTS
  After bare-metal stent implantation (n=21), significant increases in the numbers of CD34-positive cells (maximum on post-procedure day 7, P<0.001), activated Mac-1 (at 48 h, P<0.001), and active MMP-9 levels (at 24h, P<0.001) were observed. However, these changes were absent after sirolimus-eluting stent implantation (n=10). In overall patients, the numbers of CD34-positive cells on day 7 (R=0.58, P<0.01) and activated Mac-1 at 48 h (R=0.58, P<0.01) were both correlated with active MMP-9 levels at 24h. Stimulation of activated Mac-1 on the surface of isolated human neutrophils produced active MMP-9 release in vitro.
  
  
  CONCLUSIONS
  These results suggest that stent-induced activation of Mac-1 on the surface of neutrophils might trigger their MMP-9 release, possibly leading to the mobilization of bone marrow-derived stem cells. These reactions were substantially inhibited by sirolimus-eluting stents.
authors.affiliation: Department of Cardiovascular Medicine, Dokkyo Medical University, Mibu, Tochigi, Japan. inouet@dokkyomed.ac.jp
authors.forename: Teruo
authors.initials: T
authors.lastname: Inoue
authors.forename: Isao
authors.initials: I
authors.lastname: Taguchi
authors.forename: Shichiro
authors.initials: S
authors.lastname: Abe
authors.forename: Shigeru
authors.initials: S
authors.lastname: Toyoda
authors.forename: Kohsuke
authors.initials: K
authors.lastname: Nakajima
authors.forename: Masashi
authors.initials: M
authors.lastname: Sakuma
authors.forename: Koichi
authors.initials: K
authors.lastname: Node
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000295:instrumentation; D018952:Antigens, CD34 / Q000096:biosynthesis; D001854:Bone Marrow Cells / Q000502:physiology*; D002465:Cell Movement / Q000502:physiology; D003324:Coronary Artery Disease / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D004789:Enzyme Activation / Q000502:physiology; D005260:Female; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D006801:Humans; D016177:Macrophage-1 Antigen / Q000096:biosynthesis; D008297:Male; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D008875:Middle Aged; D009504:Neutrophils / Q000201:enzymology / Q000378:metabolism / Q000473:pathology; D015607:Stents / Q000009:adverse effects
chemical_list: D018952:Antigens, CD34; D016177:Macrophage-1 Antigen; D020780:Matrix Metalloproteinase 9